Collaboration with Non-Endocrinologists Using SGLT2 Inhibitors for Non-Diabetes Indications

Saturday, May 14, 2022

1:40 PM – 2:00 PM

Location: Breakout Room 5-Aqua DEF (Level 3)

Speaker(s)

Describe indications for SGLT2 inhibitors in non-diabetes patients
Review key components to successful collaboration with non-endocrinologists regarding use of SGLT2 inhibitors
Recognize innovative options for improved comprehensive cardiometabolic care

Participants should be aware of the following financial/non-financial relationships:

Kristen Kulasa, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.